{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:57:02Z","timestamp":1791687422720,"version":"4.3.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>The natural history and optimal treatment of pleomorphic (PLCIS) and florid (FLCIS) lobular carcinoma in situ variants remains uncertain. We reviewed the clinicopathologic features and management of LCIS variants at our institution over a 20-year period. Of 85 cases (61 PLCIS, 24 FLCIS), 77% were associated with invasive carcinoma (84% lobular, 13% ductal\/lobular, 3% ductal) and only 17% (9 PLCIS, 5 FLCIS) were pure. Most (81%) invasive carcinomas were grade 2, with all grade 3\/pleomorphic invasive lobular carcinomas (ILC) associated with PLCIS, and all grade 1 tumors associated with FLCIS. PLCIS-associated invasive carcinomas were more often ER\u2212 (21%) or HER2+ (14%) than FLCIS-associated tumors (100% ER+, 6% HER2+). LCIS variants were unifocal and co-localized with invasive carcinoma in 20\/20 selected spatially mapped cases, whereas classic LCIS (CLCIS) was multifocal with wider distribution (10\/17). Of 21 pure LCIS variants on core biopsy, all represented the radiographic (95%) or palpable (5%) target. The excisional upgrade rate was similar for PLCIS (38%) and FLCIS (33%). Pure LCIS variants on core biopsy were often (20%) HER2+ and had a higher Ki-67-index than synchronous CLCIS (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.002). Lower ER expression in LCIS variants versus CLCIS was due to ER\u2212 apocrine PLCIS. ER and HER2 were consistently concordant between LCIS variants and upgraded ILC but discordant between synchronous CLCIS and LCIS variants in 5\/14 (36%). Pure LCIS variants were excised to negative margins and frequently (58%) treated with endocrine but not radiation therapy without recurrences. In summary, PLCIS and FLCIS demonstrate features of direct precursor lesions warranting surgical excision.<\/jats:p>","DOI":"10.1097\/pas.0000000000001191","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:49:26Z","timestamp":1543520966000},"page":"399-408","source":"Crossref","is-referenced-by-count":52,"title":["Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast"],"prefix":"10.1097","volume":"43","author":[{"given":"Eliah R.","family":"Shamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Pekmezci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Rabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","article-title":"Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin","volume":"31","author":"Dabbs","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br J Cancer"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2010.08.010","article-title":"Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma","volume":"41","author":"Alvarado-Cabrero","year":"2010","journal-title":"Arch Med Res"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1245\/s10434-011-1563-0","article-title":"The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?","volume":"18","author":"Bagaria","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","article-title":"Lobular intraepithelial neoplasia (lobular carcinoma in situ) with comedo-type necrosis: a clinicopathologic study of 18 cases","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in situ variants in breast cores potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/1097-0142(197706)39:6<2597::AID-CNCR2820390644>3.0.CO;2-E","article-title":"Lobular carcinoma in situ of the breast. An approach to rational treatment","volume":"39","author":"Andersen","year":"1977","journal-title":"Cancer"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Lobular neoplasia. Long term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J Clin Oncol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","article-title":"Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review","volume":"165","author":"De Brot","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1806","article-title":"Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity","volume":"207","author":"Reis-Filho","year":"2005","journal-title":"J Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","article-title":"Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy","volume":"19","author":"Shah-Khan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-011-2034-3","article-title":"Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy","volume":"19","author":"Rendi","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.13121730","article-title":"Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation","volume":"269","author":"Atkins","year":"2013","journal-title":"Radiology"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/modpathol.2012.221","article-title":"Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy","volume":"26","author":"Chaudhary","year":"2013","journal-title":"Mod Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5858\/arpa.2012-0297-OA","article-title":"Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target","volume":"137","author":"D\u2019Alfonso","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1309\/AJCPYG48TUTFIBMR","article-title":"Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification","volume":"138","author":"Zhao","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","article-title":"Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis","volume":"57","author":"Carder","year":"2010","journal-title":"Histopathology"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tbj.12843","article-title":"Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast","volume":"24","author":"Fasola","year":"2018","journal-title":"Breast J"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","article-title":"Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: clinicopathologic features and correlation with subsequent excision","volume":"18","author":"Guo","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.breast.2007.04.005","article-title":"Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision","volume":"16","author":"Lavoue","year":"2007","journal-title":"Breast"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","article-title":"Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ","volume":"135","author":"Downs-Kelly","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl 2","key":"R35-20230922","first-page":"70","article-title":"Variability in diagnostic threshold for comedo necrosis among pathologists: implications for patient eligibility for active surveillance trials of DCIS","volume":"90","author":"Harrison","year":"2018","journal-title":"Lab Invest"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R38-20230922","first-page":"4241s","article-title":"Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer","volume":"46","author":"McClelland","year":"1986","journal-title":"Cancer Res"},{"key":"R39-20230922","first-page":"3545","article-title":"Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer","volume":"50","author":"McClelland","year":"1990","journal-title":"Cancer Res"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/modpathol.2008.106","article-title":"Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma","volume":"21","author":"Choi","year":"2008","journal-title":"Mod Pathol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gcc.20756","article-title":"Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression","volume":"49","author":"Boldt","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/tbj.12062","article-title":"Breast surgeon\u2019s survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ","volume":"19","author":"Blair","year":"2013","journal-title":"Breast J"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","article-title":"Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: repertoire of somatic genetic alterations and clonal relationships","volume":"10","author":"Sakr","year":"2016","journal-title":"Mol Oncol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13058-016-0789-y","article-title":"PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression","volume":"19","author":"Shah","year":"2017","journal-title":"Breast Cancer Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:13:52Z","timestamp":1720822432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00013"}},"subtitle":["A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001191","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}